SCOPUS 정보 검색 플랫폼

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 3, 2000, Pages 227-231

Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study

(7) Chaix, Carine a Grenier Sennelier, Catherine a Clevenbergh, P b Durant, J b Schapiro, J M c Dellamonica, Pierre b Durand Zaleski, Isabelle a,d

a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS (France)

b UNIVERSITY HOSPITAL OF NICE (France)

c SHEBA MEDICAL CENTER (Israel)

d HENRI MONDOR HOSPITAL (France)

Author keywords

Drug resistance; Economics; Genotyping

Indexed keywords

ANTIVIRUS AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; FEMALE; FOLLOW UP; GENETIC RESISTANCE; GENOTYPE; HEALTH CARE COST; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEINASE INHIBITION; RANDOMIZED CONTROLLED TRIAL;

EID: 0034232894 PISSN: 15254135 EISSN: None Source Type: Journal
DOI: 10.1097/00126334-200007010-00005 Document Type: Article

Times cited : (40)

References (14)

1
- 2642709177
- Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
- (1998) N Engl J Med , vol.338 , pp. 853-860
- Palella F.J., Jr.¹ Delaney, K.M.² Moorman, A.C.³

2
- 0030070991
- Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
- (1996) Science , vol.272 , pp. 1167-1170
- Mellors, J.¹ Rinaldo C., Jr.² Gupta³

3
- 0033606540
- Improving HIV therapy with drug resistance genotyping: The Viradapt randomised study
- (1999) Lancet , vol.353 , pp. 2195-2199
- Durant, J.¹ Clevenbergh, P.² Halfon, P.³

4
- 0001873619
- Persisting long-term benefit of antiretroviral genotypic guided treatment for HIV-infected patients failing HAART: The Viradapt study, week 48 follow-up
- (1999) Antiviral Ther , Issue.SUPPL. 1 , pp. 42
- Clevenbergh, P.¹ Durant, J.² Halfon, P.³

5
- 0029794708
- For the panel on cost-effectiveness in health and medicine. Recommendations of the Panel on cost-effectiveness in health and medicine
- (1996) JAMA , vol.276 , pp. 1253-1258
- Siegel, J.E.¹ Gold, M.R.² Kanlet, M.S.³

6
- 0007812695
- Methods for economic evaluation of health care programmes. Oxford: Oxford University Press
- (1996) , pp. 35-38
- Drummond, M.¹ Stoddart, G.² Torrance, G.³

7
- 0007809115
- Base nationale de couts. Paris: Ministere de la Sante
- (1999)

8
- 0032585183
- Analysis and interpretation of cost data in randomised controlled trials: Review of public studies
- (1998) BMJ , vol.317 , pp. 1195-1200
- Barber, J.¹ Thompson, S.G.²

9
- 0031775947
- Dossier medical informatise pour les patients atteints d'infection par le VIH (ADDIS)
- (1998) Med Mal Inf , vol.28 , pp. 291-295
- Pradier, C.¹ Pugliese, P.² Caissotti, C.³

10
- 0007811025
- GigaHAART: A rescue therapy in HIV infected patients with multiple failures to HAART
- Presented at the 7th Conference on Clinical Aspects and Treatment of HIV infection, Lisbon, Portugal
- (1999)
- Duvivier, C.¹ Katlama, C.² Mouroux, M.³

11
- 0032564658
- The care of HIV-infected adults in the United States
- (1998) N Engl J Med , vol.339 , pp. 1897-1904
- Bozette, S.¹ Berry, S.H.² Naihua, D.³

12
- 0033174829
- How good are U.S. studies of HIV costs of care?
- (1999) Med Care , vol.37 , pp. 748-759
- Rabeneck, L.¹ Menke, T.² Wray, N.³

13
- 0002049579
- The spectrum and frequency of reduced antiretroviral drug susceptibility with primary infection in the United States
- (1999) Antiviral Ther , Issue.SUPPL. 1 , pp. 86
- Little, S.¹ Darra, E.² Keiser, P.³

14
- 0007856919
- Drug holidays. Lecture presented at the International Conference on Antimicrobial Agents and Chemotherapy, San Francisco
- (1999)
- Miller, V.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.